AMC Media Group has been acquired by Formedics
AMC Media Group, a healthcare professional (HCP) community platform that enables medical associations and key opinion leaders (KOLs) to drive engagement and monetization through their specialty digital properties, has been acquired by Formedics, an HCP community and engagement platform that is home to Physician’s Weekly and OncWeekly.
AMC Media Group offers business development, digital advertising and healthcare publishing services to medical experts across the US. Its mission is to activate peer connections that facilitate HCP learning while helping brands access key audiences.
Formedics is an HCP community and engagement platform that supports and connects healthcare professionals wherever they practice medicine or choose to learn. In addition to its leading HCP network, Formedics’ groundbreaking AI/ML technology unlocks unrivaled healthcare targeting and engagement for pharmaceutical and life science brands. The Formedics properties include Physician’s Weekly, Figure 1, OncWeekly and AMC Media Group.
Oaklins DeSilva+Phillips, one of Oaklins’ TMT teams in New York, served as the exclusive financial advisor to AMC Media Group on the transaction. This transaction emphasizes ODP’s deep sector expertise in advising digital media businesses, specifically those within the healthcare communications and technology industry.
JC Landry
President, AMC Media Group
Talk to the deal team
Jon Guttenberg
Oaklins DeSilva+Phillips
Related deals
Outsource Management Services has been acquired by IMI Supply Chain Solutions
UK logistics software provider Outsource Management Services (OMS) has been acquired by IMI Supply Chain Solutions, a Sweden-based provider of supply chain management software solutions.
Learn moreEuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Learn moreOlyos Group has acquired a controlling stake in NewScience
Olyos Group has acquired a controlling stake in NewScience from its founders through a transaction structured in two stages, with the strategic objective of ultimately acquiring 100% of the company. The transaction forms part of NewScience’s international growth strategy and a gradual cash-out process for the founder, who intends to complete a full exit. Olyos intends to retain the management team through a put and call option mechanism and an earn-out linked to NewScience’s 2025 EBITDA.
Learn more